Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd > $RVV - From Psychedelics to Antivirals !
View:
Post by cool888 on Nov 14, 2021 8:17am

$RVV - From Psychedelics to Antivirals !



Revive which currently trades for $128 million USD is poised to make a breakout should it receive
#FDA #EUA for its Oral #Covid19
#BUCILLAMINE, which might be reasonably Expected given it’s progress in Phase 3 trials

https://www.truffle.report/from-psychedelics-to-antivirals-revive-therapeutics-remains-a-relative-value-play-among-oral-based-covid-therapeutics/?fbclid=IwAR2ITEd5f8y8XztmntHA4d2ZuRKCTTsZnSrzDT_6Uw6AO_KTZcYi4ELp9tY
Comment by Chrisxd5 on Nov 14, 2021 12:15pm
Great Article 
Comment by RandomGuy1 on Nov 14, 2021 5:05pm
Upon decent results - RVV $3 to $5 Upon EUA from FDA - RVV $10 to $15 Upon buyout or commercialization or licensing - $15 to $15 Buy in now because this is crypto-like gains without as much of the risk.....
Comment by cool888 on Nov 14, 2021 6:27pm
lol !
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities